Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
52
-
Total 13F shares, excl. options
-
11.1M
-
Shares change
-
-597K
-
Total reported value, excl. options
-
$17.4M
-
Value change
-
-$924K
-
Put/Call ratio
-
0.3
-
Number of buys
-
17
-
Number of sells
-
-23
-
Price
-
$1.57
Significant Holders of Niagen Bioscience, Inc. - COM NEW (NAGE) as of Q2 2023
65 filings reported holding NAGE - Niagen Bioscience, Inc. - COM NEW as of Q2 2023.
Niagen Bioscience, Inc. - COM NEW (NAGE) has 52 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.1M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (3.04M shares), Tieton Capital Management, LLC (2.57M shares), ICONIQ Capital, LLC (1.3M shares), BlackRock Inc. (914K shares), GEODE CAPITAL MANAGEMENT, LLC (524K shares), RENAISSANCE TECHNOLOGIES LLC (461K shares), GMT CAPITAL CORP (297K shares), MILLENNIUM MANAGEMENT LLC (281K shares), GAMCO INVESTORS, INC. ET AL (205K shares), and STATE STREET CORP (190K shares).
This table shows the top 52 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.